» Articles » PMID: 10630153

Time to Diagnosis and Treatment of Breast Cancer: Results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995

Overview
Specialty Public Health
Date 2000 Jan 12
PMID 10630153
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study examined times to diagnosis and treatment for medically underserved women screened for breast cancer.

Methods: Intervals from first positive screening test to diagnosis to initiation of treatment were determined for 1659 women 40 years and older diagnosed with breast cancer.

Results: Women with abnormal mammograms had shorter diagnostic intervals than women with abnormal clinical breast examinations and normal mammograms. Women with self-reported breast symptoms had shorter diagnostic intervals than asymptomatic women. Diagnostic intervals were less than 60 days in 78% of cases. Treatment intervals were generally 2 weeks or less.

Conclusions: Most women diagnosed with breast cancer were followed up in a timely manner after screening. Further investigation is needed to identify and then address factors associated with longer diagnostic and treatment intervals to maximize the benefits of early detection.

Citing Articles

Individual and area level factors associated with the breast cancer diagnostic-treatment interval in Queensland, Australia.

Retell J, Cameron J, Aitken J, Youl P, Pyke C, Dunn J Breast Cancer Res Treat. 2023; 203(3):575-586.

PMID: 37930491 PMC: 10805972. DOI: 10.1007/s10549-023-07134-4.


Factors Associated with the Breast Cancer Diagnostic Interval across Five Canadian Provinces: A CanIMPACT Retrospective Cohort Study.

Ruco A, Groome P, McBride M, Decker K, Grunfeld E, Jiang L Cancers (Basel). 2023; 15(2).

PMID: 36672357 PMC: 9857089. DOI: 10.3390/cancers15020404.


Health system barriers influencing timely breast cancer diagnosis and treatment among women in low and middle-income Asian countries: evidence from a mixed-methods systematic review.

Afaya A, Ramazanu S, Bolarinwa O, Yakong V, Afaya R, Aboagye R BMC Health Serv Res. 2022; 22(1):1601.

PMID: 36587198 PMC: 9805268. DOI: 10.1186/s12913-022-08927-x.


Breast Cancer Care Timeliness Framework: A Quality Framework for Cancer Control.

Mohd Mujar N, Dahlui M, Emran N, Hadi I, Yan Y, Arulanantham S JCO Glob Oncol. 2022; 8:e2100250.

PMID: 35286134 PMC: 8932493. DOI: 10.1200/GO.21.00250.


Assessment of Breast Cancer Treatment Delay Impact on Prognosis and Survival: a Look at the Evidence from Systematic Analysis of the Literature.

Williams F J Cancer Biol Res. 2021; 3(4).

PMID: 34258389 PMC: 8274552.


References
1.
Dennis C, Gardner B, Lim B . Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer. Cancer. 1975; 35(3):714-20. DOI: 10.1002/1097-0142(197503)35:3<714::aid-cncr2820350326>3.0.co;2-v. View

2.
Wei M, Gibbons L, Mitchell T, Kampert J, Lee C, Blair S . The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann Intern Med. 1999; 130(2):89-96. DOI: 10.7326/0003-4819-130-2-199901190-00002. View

3.
Williams E, Baum M, Hughes L . Delay in presentation of women with breast disease. Clin Oncol. 1976; 2(4):327-31. View

4.
Wilkinson G, Edgerton F, WALLACE Jr H, Reese P, Patterson J, Priore R . Delay, stage of disease and survival from breast cancer. J Chronic Dis. 1979; 32(5):365-73. DOI: 10.1016/0021-9681(79)90078-x. View

5.
Adam S, Horner J, Vessey M . Delay in treatment for breast cancer. Community Med. 1980; 2(3):195-201. DOI: 10.1007/BF02549023. View